Internal Medicine, Nephrology · Ocala, FL
NPI
1588602494
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2980 SE 3rd Ct
Ocala, FL, 34471
Phone (352) 622-4231
Groups this clinician bills Medicare through
Medicare paid, 2024
$176K
1,894 services
Medicare patients, 2024
338
Average age 75
Drug cost, 2024
$100K
1,075 prescriptions
Company payments, 2025
$976
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mahesh K Vaghela was code 99233 (hospital e&m - subsequent), 577 times for 148 patients. In total Mahesh K Vaghela billed 1,894 services in 24 codes, and Medicare paid $176K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 577 | 148 | $91.39 | $53K |
| 99214 Office E&M - Established | Office | 276 | 137 | $60.84 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 233 | 134 | $12.57 | $2,929 |
| 99223 Hospital E&M - Initial | Facility | 182 | 135 | $133.77 | $24K |
| 90960 ESRD Related Services (not dialysis) | Office | 133 | 33 | $282.20 | $38K |
| 99458 E&M - Miscellaneous | Office | 69 | 19 | $30.45 | $2,101 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 58 | 14 | $37.11 | $2,152 |
| 90961 ESRD Related Services (not dialysis) | Office | 52 | 19 | $234.28 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 50 | 40 | $59.56 | $2,978 |
| 90962 ESRD Related Services (not dialysis) | Office | 47 | 16 | $161.15 | $7,574 |
| 99457 E&M - Miscellaneous | Office | 45 | 19 | $37.57 | $1,691 |
| 99454 E&M - Miscellaneous | Office | 29 | 17 | $34.98 | $1,014 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 29 | 14 | $48.65 | $1,411 |
| 99215 Office E&M - Established | Office | 20 | 20 | $119.20 | $2,384 |
| 99453 E&M - Miscellaneous | Office | 17 | 17 | $14.99 | $255 |
By year: 2022 $172K for 1,557 services; 2023 $177K for 1,453 services; 2024 $176K for 1,894 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mahesh K Vaghela prescribed most often to Medicare patients was Prednisone, with 88 prescriptions and refills. In total Mahesh K Vaghela wrote 1,075 Medicare prescriptions that cost $100K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 88 | 190 | 22 | $546 |
| Sps Sodium Polystyrene Sulfon/Sorb | 87 | 96 | 33 | $17K |
| Furosemide Generic | 73 | 193 | 27 | $543 |
| Metoprolol Tartrate Generic | 51 | 127 | 15 | $337 |
| Sevelamer Carbonate Generic | 51 | 134 | 19 | $16K |
| Carvedilol Generic | 46 | 92 | Under 11 | $300 |
| Lisinopril Generic | 45 | 133 | 16 | $295 |
| Amlodipine Besylate Generic | 25 | 75 | Under 11 | $351 |
| Allopurinol Generic | 24 | 72 | Under 11 | $266 |
| Losartan Potassium Generic | 23 | 69 | Under 11 | $379 |
| Metolazone Generic | 23 | 71 | Under 11 | $406 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 22 | 52 | Under 11 | $224 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 20 | 39 | Under 11 | $127 |
| Calcitriol Generic | 20 | 59 | Under 11 | $294 |
| Tacrolimus Generic | 19 | 33 | Under 11 | $1,055 |
Brand drugs: 90 claims; generic drugs: 985 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mahesh K Vaghela $976 ($976 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $231.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 15 | $231 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $97.7 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $66.03 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63.62 |
| Calliditas Therapeutics US Inc. | 3 | $62.05 |
| Ardelyx, Inc. ARDX | 3 | $59.6 |
| Outset Medical Inc OM | 2 | $50.25 |
| Travere Therapeutics, Inc. TVTX | 4 | $48.82 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $48.11 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $47.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.